USD 1.24
(-7.84%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 1.00 USD | -100.0% |
2022 | 1.25 Million USD | 0.0% |
2021 | 1.25 Million USD | 124999900.0% |
2020 | 1.00 USD | -100.0% |
2019 | 648 Thousand USD | 0.0% |
2018 | - USD | -100.0% |
2017 | 735 Thousand USD | -32.01% |
2016 | 1.08 Million USD | 0.0% |
2015 | - USD | -100.0% |
2014 | 4.95 Million USD | -77.63% |
2013 | 22.14 Million USD | 230.57% |
2012 | 6.69 Million USD | 0.0% |
2011 | - USD | 100.0% |
2010 | -239.87 Million USD | 0.0% |
2009 | - USD | -100.0% |
2008 | 2.49 Million USD | 0.0% |
2007 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | - USD | -100.0% |
2024 Q2 | - USD | 0.0% |
2023 Q4 | 1.00 USD | -100.0% |
2023 Q3 | 788 Thousand USD | 0.0% |
2023 Q2 | 788 Thousand USD | -36.96% |
2023 Q1 | 1.25 Million USD | 0.0% |
2023 FY | 1.00 USD | -100.0% |
2022 Q3 | - USD | 0.0% |
2022 Q4 | 1.25 Million USD | 0.0% |
2022 FY | 1.25 Million USD | 0.0% |
2022 Q1 | - USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 Q1 | 1.00 USD | 0.0% |
2021 FY | 1.25 Million USD | 124999900.0% |
2021 Q2 | - USD | -100.0% |
2021 Q4 | - USD | 0.0% |
2020 Q4 | 1.00 USD | 0.0% |
2020 FY | 1.00 USD | -100.0% |
2020 Q1 | 1.00 USD | -100.0% |
2020 Q2 | 1.00 USD | 0.0% |
2020 Q3 | - USD | -100.0% |
2019 FY | 648 Thousand USD | 0.0% |
2019 Q2 | 1.73 Million USD | 192.58% |
2019 Q3 | 2.29 Million USD | 32.45% |
2019 Q4 | 648 Thousand USD | -71.8% |
2019 Q1 | 593 Thousand USD | 0.0% |
2018 Q4 | - USD | -100.0% |
2018 FY | - USD | -100.0% |
2018 Q3 | 76 Thousand USD | -93.08% |
2018 Q2 | 1.09 Million USD | -35.54% |
2018 Q1 | 1.7 Million USD | 131.97% |
2017 Q2 | - USD | -100.0% |
2017 FY | 735 Thousand USD | -32.01% |
2017 Q3 | 479 Thousand USD | 0.0% |
2017 Q4 | 735 Thousand USD | 53.44% |
2017 Q1 | 1.51 Million USD | 39.96% |
2016 FY | 1.08 Million USD | 0.0% |
2016 Q3 | 1.00 USD | 0.0% |
2016 Q4 | 1.08 Million USD | 108099900.0% |
2016 Q1 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2015 Q3 | 1.00 USD | 0.0% |
2015 Q4 | - USD | -100.0% |
2015 Q1 | 4.95 Million USD | -0.08% |
2015 FY | - USD | -100.0% |
2015 Q2 | - USD | -100.0% |
2014 Q4 | 4.95 Million USD | -62.02% |
2014 Q1 | 23.41 Million USD | 5.73% |
2014 Q2 | 12.98 Million USD | -44.52% |
2014 Q3 | 13.04 Million USD | 0.43% |
2014 FY | 4.95 Million USD | -77.63% |
2013 Q1 | 19.7 Million USD | 194.13% |
2013 Q4 | 22.14 Million USD | 7.7% |
2013 Q3 | 20.56 Million USD | 0.89% |
2013 Q2 | 20.37 Million USD | 3.43% |
2013 FY | 22.14 Million USD | 230.57% |
2012 Q2 | -151.68 Million USD | 23.41% |
2012 Q1 | -198.06 Million USD | 0.0% |
2012 Q4 | 6.69 Million USD | 594.2% |
2012 Q3 | 965 Thousand USD | 100.64% |
2012 FY | 6.69 Million USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q2 | - USD | 100.0% |
2011 Q1 | -216.27 Million USD | 0.0% |
2011 FY | - USD | 100.0% |
2011 Q3 | - USD | 0.0% |
2010 FY | -239.87 Million USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q2 | - USD | 100.0% |
2010 Q1 | -295.46 Million USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 FY | - USD | -100.0% |
2008 Q4 | 2.49 Million USD | 0.0% |
2008 FY | 2.49 Million USD | 0.0% |
2007 FY | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Cosmos Health Inc. | 4.78 Million USD | 100.0% |
Safety Shot Inc | 1.86 Million USD | 100.0% |
Bright Green Corporation | - USD | -Infinity% |
Embecta Corp. | 152.1 Million USD | 100.0% |
ANI Pharmaceuticals, Inc. | 111.19 Million USD | 100.0% |
Aquestive Therapeutics, Inc. | 6.76 Million USD | 100.0% |
Collegium Pharmaceutical, Inc. | 32.33 Million USD | 100.0% |
Dynavax Technologies Corporation | 53.29 Million USD | 100.0% |
Esperion Therapeutics, Inc. | 65.62 Million USD | 100.0% |
Intra-Cellular Therapies, Inc. | 11.64 Million USD | 100.0% |
Pacira BioSciences, Inc. | 104.35 Million USD | 100.0% |
PainReform Ltd. | - USD | -Infinity% |
Sunshine Biopharma, Inc. | 5.73 Million USD | 100.0% |
Sunshine Biopharma, Inc. | 5.73 Million USD | 100.0% |
SCYNEXIS, Inc. | - USD | -Infinity% |
China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | 100.0% |
Journey Medical Corporation | 10.2 Million USD | 100.0% |
Alpha Teknova, Inc. | 11.59 Million USD | 100.0% |
Procaps Group, S.A. | 96.83 Million USD | 100.0% |
Theratechnologies Inc. | 6.06 Million USD | 100.0% |
Harrow Health, Inc. | 10.86 Million USD | 100.0% |
Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | 100.0% |
Biofrontera Inc. | 10.9 Million USD | 100.0% |
DURECT Corporation | 2.21 Million USD | 100.0% |
Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 100.0% |
Cronos Group Inc. | 30.33 Million USD | 100.0% |
OptiNose, Inc. | 8.05 Million USD | 100.0% |
Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
RedHill Biopharma Ltd. | 5.69 Million USD | 100.0% |
Organogenesis Holdings Inc. | 28.25 Million USD | 100.0% |
Guardion Health Sciences, Inc. | 2.67 Million USD | 100.0% |
Cumberland Pharmaceuticals Inc. | 4.6 Million USD | 100.0% |
Radius Health, Inc. | 278.64 Million USD | 100.0% |
Universe Pharmaceuticals INC | 3.34 Million USD | 100.0% |
ProPhase Labs, Inc. | 3.84 Million USD | 100.0% |
Phibro Animal Health Corporation | 265.91 Million USD | 100.0% |
Procaps Group S.A. | 96.83 Million USD | 100.0% |
Alvotech | 74.43 Million USD | 100.0% |
TherapeuticsMD, Inc. | - USD | -Infinity% |
Viatris Inc. | 3.46 Billion USD | 100.0% |
Rockwell Medical, Inc. | 5.87 Million USD | 100.0% |
Aytu BioPharma, Inc. | 12.63 Million USD | 100.0% |
SIGA Technologies, Inc. | 64.21 Million USD | 100.0% |
Tilray Brands, Inc. | 252.08 Million USD | 100.0% |
Lifecore Biomedical, Inc. | 39.97 Million USD | 100.0% |
Shineco, Inc. | 1.58 Million USD | 100.0% |
PetIQ, Inc. | 159.3 Million USD | 100.0% |
Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 100.001% |
Incannex Healthcare Limited | -10.01 Million USD | 100.0% |
Neurocrine Biosciences, Inc. | 38.3 Million USD | 100.0% |
Alimera Sciences, Inc. | 1.87 Million USD | 100.0% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Assertio Holdings, Inc. | 37.68 Million USD | 100.0% |
Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
Petros Pharmaceuticals, Inc. | 1.61 Million USD | 100.0% |
Clever Leaves Holdings Inc. | 4.48 Million USD | 100.0% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | 100.0% |
Avadel Pharmaceuticals plc | 10.38 Million USD | 100.0% |
Hempacco Co., Inc. | 2.54 Million USD | 100.0% |
Talphera, Inc. | - USD | -Infinity% |
Alvotech | 74.43 Million USD | 100.0% |
Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 100.0% |
Lantheus Holdings, Inc. | 64.02 Million USD | 100.0% |
Currenc Group, Inc. | 732.91 Thousand USD | 100.0% |
Kamada Ltd. | 87.74 Million USD | 100.0% |
Indivior PLC | 141.79 Million USD | 100.0% |
Evoke Pharma, Inc. | 481.84 Thousand USD | 100.0% |
Flora Growth Corp. | 8.5 Million USD | 100.0% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | 100.0% |
Evolus, Inc. | 10.99 Million USD | 100.0% |
HUTCHMED (China) Limited | 50.25 Million USD | 100.0% |
Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 100.0% |
Akanda Corp. | 1.28 Million USD | 100.0% |